Clinical Updates
Drug approvals, guideline changes, and treatment advances
MHRA Approves First Needle-Free Adrenaline Nasal Spray for Young Children
UK regulators approve the first needle-free adrenaline nasal spray for children as young as 12 months, offering a breakthrough treatment…
Editor's Top Picks
Pfizer’s Monthly Obesity Drug Shows Promise in Detailed Midstage Trial Data
Detailed midstage trial data provide further evidence that Pfizer's obesity drug berobenatide, acquired from Metsera, could offer effective weight management…
Submit Your Paper →
More form Clinical Updates
Medical Dosing Based on Race Lacks Scientific Evidence and May Harm Patients, NEJM Analysis Warns
New NEJM analysis challenges race-based medication dosing, arguing it lacks scientific foundation and may harm…
NEJM Images Show Advanced Diabetic Eye Disease Progression and Treatment Response
New NEJM clinical images demonstrate proliferative diabetic retinopathy progression, showing characteristic neovascularization of the optic…
Novel PET Tracer Detects Blood Clots in Legs and Lungs with Single Scan
Novel PET radiotracer enables simultaneous detection of deep vein thrombosis and pulmonary embolism in single…
AI-Enhanced Scans and Immune-Targeting Drugs Transform Heart Inflammation Detection
AI-enhanced imaging and immune-targeting drugs are revolutionizing cardiac inflammation detection and treatment. Nature Medicine reports…
Spinal Cord Stimulation Shows Promise for Stroke Recovery in Small Trial
Small clinical trial shows epidural spinal cord stimulation safely improved arm function in seven chronic…